BIOSECURE Act & Geopolitical Bifurcation: US-China Biotech Ecosystem Separation
Description
BIOSECURE Act passed December 2025. 'Biotech companies of concern' list still evolving. Cross-border collaboration disrupted. Comprehensive analysis of geopolitical bifurcation, IP management, and competitive implications.
Table of Contents
76 Pages
- EXECUTIVE SUMMARY
- 1.1 BIOSECURE Act Overview
- 1.2 Geopolitical Risk Assessment
- 2.0 PROHIBITED ACTIVITIES
- 2.1 Restricted Collaborations
- 2.2 Investment Limitations
- 2.3 Employee Restrictions
- 3.0 IP MANAGEMENT STRATEGY
- 3.1 IP Relocation Planning
- 3.2 Collaboration Risk Assessment
- 3.3 Asset Protection
- 4.0 SUPPLY CHAIN REBALANCING
- 4.1 Alternative Sourcing
- 4.2 Dual-Source Strategy
- 4.3 Nearshoring Opportunities
- 5.0 ORGANIZATIONAL STRATEGY
- 5.1 Compliance Framework
- 5.2 Government Relations
- 5.3 Strategic Options
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

